AIM ImmunoTech Inc. also files under HEB; those filings are included. Filings under AIM by Aerosonic Corp (CIK 0000109471) from Mar 17, 2006 to Jun 5, 2013 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Equels Thomas K | CEO & President, Director | Conversion(C) | 25 | — | $0 |
| Mar 12, 2026 | Chemerow David I. | Director | Conversion(C) | 25K | — | $0 |
| Mar 12, 2026 | Chemerow David I. | Director | Conversion(C) | 25 | — | $0 |
| Mar 12, 2026 | Equels Thomas K | CEO & President, Director | Conversion(C) | 25K | — | $0 |
| Mar 6, 2026 | Equels Thomas K | CEO & President | Other(J) | 25 | $25,000.00as filed | — |
| Mar 6, 2026 | Equels Thomas K | CEO & President | Other(J) | 50K | — | $0 |
| Mar 6, 2026 | Chemerow David I. | Director | Other(J) | 50K | — | $0 |
| Mar 6, 2026 | Chemerow David I. | Director | Other(J) | 25 | $25,000.00as filed | — |
| Feb 5, 2026 | Chemerow David I. | Director | Grant(A) | 3K | $1.23 | $3K |
| Jun 13, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 107 | $7.70 | $824 |
| Jun 12, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 103 | $8.70 | $896 |
| Apr 11, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 2.0M | $0.03 | $59K |
| Apr 11, 2025 | Kellner Ted D | Director | Buy(P) | 2.0M | $0.03 | $59K |
| Apr 11, 2025 | Mitchell William M | Director | Buy(P) | 197K | $0.03 | $6K |
| Apr 4, 2025 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy(P) | 500 | $0.09 | $45 |
| Apr 4, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 41K | $0.06 | $2K |
| Mar 14, 2025 | Mitchell William M | Director | Grant(A) | 45K | $0.12 | $5K |
| Mar 14, 2025 | Bryan Nancy | Director | Grant(A) | 45K | $0.12 | $5K |
| Mar 14, 2025 | Chemerow David I. | Director | Grant(A) | 45K | $0.12 | $5K |
| Mar 5, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 50K | $0.13 | $7K |
| Mar 4, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 44K | $0.12 | $5K |
| Mar 4, 2025 | Equels Thomas K | CEO & President, Director | Buy(P) | 83K | $0.12 | $10K |
| Feb 28, 2025 | Chemerow David I. | Director | Grant(A) | 19K | $0.14 | $3K |
| Feb 28, 2025 | Mitchell William M | Director | Grant(A) | 39K | $0.14 | $5K |
| Feb 28, 2025 | Bryan Nancy | Director | Grant(A) | 39K | $0.14 | $5K |
| Feb 14, 2025 | Mitchell William M | Director | Grant(A) | 43K | $0.12 | $5K |
| Feb 14, 2025 | Bryan Nancy | Director | Grant(A) | 43K | $0.12 | $5K |
| Jan 31, 2025 | Mitchell William M | Director | Grant(A) | 26K | $0.20 | $5K |
| Jan 31, 2025 | Bryan Nancy | Director | Grant(A) | 26K | $0.20 | $5K |
| Jan 15, 2025 | Bryan Nancy | Director | Grant(A) | 27K | $0.19 | $5K |
| Jan 15, 2025 | Mitchell William M | Director | Grant(A) | 27K | $0.19 | $5K |
| Dec 31, 2024 | Appelrouth Stewart | Director | Grant(A) | 9K | $0.20 | $2K |
| Dec 31, 2024 | Bryan Nancy | Director | Grant(A) | 26K | $0.20 | $5K |
| Dec 31, 2024 | Mitchell William M | Director | Grant(A) | 26K | $0.20 | $5K |
| Dec 19, 2024 | Mitchell William M | Director | Sell(S) | 5K | $0.19 | $870 |
| Dec 18, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 23K | $0.21 | $5K |
| Dec 13, 2024 | Mitchell William M | Director | Grant(A) | 24K | $0.21 | $5K |
| Dec 13, 2024 | Appelrouth Stewart | Director | Grant(A) | 24K | $0.21 | $5K |
| Dec 13, 2024 | Bryan Nancy | Director | Grant(A) | 24K | $0.21 | $5K |
| Dec 2, 2024 | Appelrouth Stewart | Director | Buy(P) | 1 | $0.21 | $0 |
| Dec 2, 2024 | Appelrouth Stewart | Director | Buy(P) | 11K | $0.21 | $2K |
| Dec 2, 2024 | Mitchell William M | Director | Grant(A) | 23K | $0.23 | $5K |
| Dec 2, 2024 | Appelrouth Stewart | Director | Grant(A) | 23K | $0.23 | $5K |
| Dec 2, 2024 | Bryan Nancy | Director | Grant(A) | 23K | $0.23 | $5K |
| Nov 21, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 20K | $0.21 | $4K |
| Nov 20, 2024 | Appelrouth Stewart | Director | Buy(P) | 82K | $0.19 | $16K |
| Nov 20, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 85K | $0.20 | $17K |
| Nov 20, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 60K | $0.18 | $11K |
| Sep 16, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 5K | $0.30 | $2K |
| Sep 13, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 20K | $0.31 | $6K |
| Sep 11, 2024 | Equels Thomas K | CEO & President, Director | Grant(A) | 313K | $0.32 | $100K |
| Aug 12, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Grant(A) | 189K | $0.27 | $51K |
| Aug 12, 2024 | Equels Thomas K | CEO & President, Director | Grant(A) | 377K | $0.27 | $102K |
| May 6, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 62K | $0.41 | $25K |
| May 6, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy(P) | 31K | $0.41 | $13K |
| Mar 21, 2024 | Bryan Nancy | Director | Buy(P) | 38K | $0.39 | $15K |
| Mar 15, 2024 | Appelrouth Stewart | Director | Buy(P) | 91K | $0.33 | $30K |
| Mar 15, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy(P) | 38K | $0.33 | $13K |
| Mar 15, 2024 | Equels Thomas K | CEO & President, Director | Buy(P) | 76K | $0.33 | $25K |
| Nov 30, 2023 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Grant(A) | 100K | — | $0 |
| Nov 30, 2023 | Equels Thomas K | CEO & President, Director | Grant(A) | 300K | — | $0 |
| Nov 27, 2023 | Equels Thomas K | CEO & President, Director | Buy(P) | 34K | $0.44 | $15K |
| Sep 29, 2023 | Equels Thomas K | CEO & President, Director | Buy(P) | 23K | $0.44 | $10K |
| Aug 25, 2023 | Equels Thomas K | CEO & President, Director | Buy(P) | 8K | $0.67 | $6K |
| Aug 24, 2023 | Equels Thomas K | CEO & President, Director | Buy(P) | 15K | $0.67 | $10K |
| Jul 17, 2023 | Equels Thomas K | CEO & President, Director | Buy(P) | 17K | $0.59 | $10K |
| Mar 10, 2023 | Appelrouth Stewart | Director | Other(J) | 68K | $1.23 | $84K |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 150 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 143 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 25K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 196 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 196 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 250 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 287 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 295 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 338 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 25K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 25K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 568 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 2K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 11 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 2K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 1K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 2K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 1K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 163 | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 1K | — | $0 |
| Mar 8, 2023 | Appelrouth Stewart | Director | Other(J) | 3K | — | $0 |
| Jan 3, 2023 | Equels Thomas K | CEO & President, Director | Buy(P) | 161K | $0.31 | $50K |
| Jan 3, 2023 | Appelrouth Stewart | Director | Buy(P) | 81K | $0.31 | $25K |
| Jan 3, 2023 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy(P) | 81K | $0.31 | $25K |
| Nov 30, 2022 | Equels Thomas K | CEO & President, Director | Grant(A) | 300K | — | $0 |
| Nov 30, 2022 | Appelrouth Stewart | Director | Grant(A) | 50K | — | $0 |
| Nov 30, 2022 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Grant(A) | 100K | — | $0 |
| Nov 30, 2022 | Mitchell William M | Director | Grant(A) | 50K | — | $0 |
| Jul 18, 2022 | Equels Thomas K | CEO & President, Director | Grant(A) | 33K | $0.76 | $25K |
| Apr 25, 2022 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Grant(A) | 5K | $1.02 | $5K |
| Apr 25, 2022 | Appelrouth Stewart | Director | Grant(A) | 25K | $1.07 | $26K |
| Apr 25, 2022 | Equels Thomas K | CEO & President, Director | Grant(A) | 49K | $1.02 | $50K |
| Mar 3, 2022 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Grant(A) | 50K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: AIM ImmunoTech Inc., SEC CIK 0000946644. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AIM and shows every filing by that issuer (also filed as HEB). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AIM